Takeda’s BLA for dengue vaccine candidate granted priority review by US FDA
TAK-003 is being evaluated for the prevention of dengue disease caused by any dengue virus serotype in individuals four years…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biologics Licence Application
Gilead submits Biologics Licence Application to USFDA for Bulevirtide
If approved, Bulevirtide will be the first treatment option for adult patients in the US with chronic Hepatitis Delta Virus…